Genasys Inc.

Genasys Inc. announced preliminary unaudited financial results for its fiscal fourth quarter and full fiscal year 2026. The company expects fiscal year 2026 revenue to be between $60.5 million and $62.0 million, with adjusted EBITDA between $7.2 million and $8.2 million. Fourth quarter revenue is projected to be between $20.5 million and $22.0 million. The company also announced its full financial results will be released on December 15, 2026, with a conference call scheduled for the same day.

Genasys Inc. reported a significant narrowing of its net loss for the nine months ended June 30, 2026, to $4.77 million, alongside a 68% increase in total revenues to $39.87 million. For the three-month period, net loss also improved to $4.68 million, despite a decrease in total revenues to $7.30 million. However, the company's stockholders' equity shifted to a deficit of $(1.32) million.

Genasys Inc. reported fiscal third quarter 2026 results with revenue of $7.3 million, down from $9.9 million in the prior year, attributed to supply chain delays and payment pacing. Despite the revenue decline, the company significantly improved its gross margin to 57.1% and narrowed its GAAP operating loss to ($4.0) million and GAAP net loss to ($4.7) million. Management highlighted strategic actions including extending a $15.2 million term loan and securing new orders, expressing confidence in a strong fourth quarter and a record year for revenue and profitability.

Genasys Inc. announced preliminary fiscal third quarter 2026 results, expecting total revenue between $7.0 million and $7.5 million. This was impacted by supply chain constraints for the CROWS II program and payment delays for the Puerto Rico Dams EWS project, both of which have since been resolved or are being addressed. Gross margins are anticipated to be 55% to 58%, with an adjusted EBITDA loss of ($3.0) million to ($3.3) million. The company expects a strong fiscal fourth quarter, with full-year expectations remaining intact, and will host a conference call on August 13, 2026, to discuss complete results.

Genasys Inc. has amended its Term Loan and Security Agreement, extending the maturity date of its $15.2 million term loan from July 2026 to July 2027. The amendment maintains the interest rate at three-month SOFR plus 5% but introduces a 20% guaranteed minimum return (MOIC) and requires $1 million monthly payments starting October 2026. Concurrently, the company amended its warrant agreement, extending the exercise period to May 2030 and reducing the exercise price to $2.28 per share, aiming to provide financial flexibility for growth.

Genasys Inc. has entered into a $4.3 million unsecured term loan agreement with Maran Partners Fund, LP. The loan bears an 18% annual interest rate and matures on September 14, 2026. Proceeds will fund working capital and general corporate needs. The agreement includes a $301,000 origination fee deducted from the principal and potential exit fees based on repayment timing.

Genasys Inc. reported a significant increase in revenue and a swing to net income for the three months ended March 31, 2026. Total revenues surged by 124% year-over-year to $15.5 million, leading to a net income of $0.72 million, compared to a net loss of $6.14 million in the prior year. For the six-month period, the company also saw substantial revenue growth and a reduced net loss, indicating improved financial performance.

Genasys Inc. reported strong fiscal Q2 2026 financial results, with revenue increasing significantly to $15.5 million and a return to GAAP net income of $0.7 million, or $0.02 per share. The company also achieved a gross margin of 63.3% and adjusted EBITDA of $2.5 million, marking a quarter of clear momentum and profitability. Additionally, Genasys extended the maturity date of its term loan from May 13, 2026, to July 13, 2026, in exchange for a 1.0% extension fee, aligning it with expected contractual cash receipts from the Puerto Rico EWS project.